MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Threshold Pharmaceuticals Company Profile (NASDAQ:THLD)

Consensus Ratings for Threshold Pharmaceuticals (NASDAQ:THLD) (?)
Ratings Breakdown: 3 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 2.40)
Consensus Price Target: $13.00 (3,321.05% upside)

Analysts' Ratings History for Threshold Pharmaceuticals (NASDAQ:THLD)
Show:
DateFirmActionRatingPrice TargetActions
12/7/2015Piper JaffrayDowngradeOverweight -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/7/2015Cowen and CompanyDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/7/2015Stifel NicolausDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/5/2015Cantor FitzgeraldReiterated RatingBuy$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/15/2015RBC CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/4/2015MLV & Co.Set Price TargetBuy$14.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/5/2014HC WainwrightInitiated CoverageBuy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/8/2014Brean CapitalInitiated CoverageBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/27/2014 forward)
Earnings History for Threshold Pharmaceuticals (NASDAQ:THLD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/28/2016        
5/5/2016Q1($0.02)($0.11)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/10/2016Q4($0.11)$0.86ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/2/2015Q315($0.14)($0.09)$3.69 million$3.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2015Q2($0.14)($0.12)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2015($0.14)($0.17)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/3/2015Q414($0.13)($0.12)$3.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2014Q314($0.12)($0.15)$3.82 million$3.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2014($0.13)($0.12)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2014($0.10)($0.12)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/6/2014Q413($0.10)($0.13)$3.58 million$3.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2013Q313($0.14)$0.02$3.15 million$3.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2013Q1 2013($0.09)($0.16)$2.80 million$2.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/2/2012Q312($0.06)($0.06)$2.29 million$1.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Threshold Pharmaceuticals (NASDAQ:THLD)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.15)($0.15)($0.15)
Q2 20161($0.12)($0.12)($0.12)
Q3 20161($0.12)($0.12)($0.12)
Q4 20161($0.12)($0.12)($0.12)
Q1 20171($0.09)($0.09)($0.09)
Q2 20171($0.09)($0.09)($0.09)
Q3 20171($0.10)($0.10)($0.10)
Q4 20171($0.10)($0.10)($0.10)
(Data provided by Zacks Investment Research)
Dividend History for Threshold Pharmaceuticals (NASDAQ:THLD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Threshold Pharmaceuticals (NASDAQ:THLD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
2/18/2015Wilfred E JaegerDirectorBuy25,000$3.75$93,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/13/2014Nipun DavarVPBuy3,000$2.99$8,970.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014Hill Ventures SutterMajor ShareholderSell226,657$3.77$854,496.89View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014Jeffrey W BirdDirectorSell238,520$3.77$899,220.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/20/2014David L AndersonMajor ShareholderSell13,988$4.01$56,091.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/16/2014Wilfred JaegerDirectorSell96,356$4.86$468,290.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/15/2014Wilfred JaegerDirectorSell424,956$4.87$2,069,535.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/10/2014Wilfred JaegerDirectorSell723,900$4.88$3,532,632.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2013Wilfred E JaegerDirectorSell322,000$5.53$1,780,660.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/11/2013Wilfred E JaegerDirectorSell178,000$5.51$980,780.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/5/2013Wilfred E JaegerDirectorSell219,667$5.53$1,214,758.51View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/19/2013Wilfred E JaegerDirectorSell2,000$5.50$11,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/18/2013Wilfred E JaegerDirectorSell124,733$5.51$687,278.83View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2013Wilfred E JaegerDirectorSell153,600$5.48$841,728.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/31/2013David L AndersonMajor ShareholderSell266,542$5.72$1,524,620.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/31/2013Jeffrey W BirdDirectorSell273,181$5.72$1,562,595.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2013Tillman PearceInsiderSell20,000$5.63$112,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Threshold Pharmaceuticals (NASDAQ:THLD)
DateHeadline
06/26/16 08:52 AMThreshold Pharmaceuticals Inc. (THLD) Jumps 7.14% on June 23 - Equities.com
06/24/16 09:20 AMRecently Issued Stock Ratings For Threshold Pharmaceuticals, Inc. (THLD) - Fiscal Standard
06/23/16 07:31 PMThreshold Pharmaceuticals, Inc. (NASDAQ:THLD) Earnings Glance and Target Price Review - Engelwood Daily
06/15/16 06:40 PMHC Stocks in Top Row: Threshold Pharmaceuticals, Inc. (NASDAQ:THLD), Intercept Pharmaceuticals Inc (NASDAQ:ICPT) - share market updates (press release)
06/13/16 09:45 AMThreshold Pharmaceuticals Inc. (NASDAQ:THLD) decreased -4.00%: Weatherford International plc (NYSE:WFT ... - KC Register
06/09/16 07:18 PMEarnings Expectations of the Stocks: Francesca's Holdings Corporation (FRAN), Threshold Pharmaceuticals Inc. (THLD) - Beacon Chronicle
06/08/16 09:54 AMStocks Earnings Analysis Report: Threshold Pharmaceuticals Inc. (NASDAQ:THLD), Entergy Corporation (NYSE:ETR) - Beacon Chronicle
06/08/16 09:54 AMTHRESHOLD PHARMACEUTICALS INC. (NASDAQ:THLD) Financial Condition Compared to S&P 500 - CML News
06/08/16 09:54 AMThreshold Pharmaceuticals Inc. (THLD) Jumps 8.43% on June 06 - Equities.com
06/07/16 07:03 PMComprehensive Analysis of: Tsakos Energy Navigation Limited (NYSE:TNP), Threshold Pharmaceuticals Inc ... - Beacon Chronicle
06/07/16 09:41 AMTraders Targeted Movers: Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) , Alkermes plc (NASDAQ:ALKS) - Street Updates
06/06/16 07:48 AMThreshold Pharmaceuticals Highlights Multiple Presentations at the 2016 ASCO Annual Meeting - [at noodls] - June 6, 2016 Presentation of additional subset data from Phase 3 MAESTRO trial of evofosfamide in pancreatic cancer demonstrates meaningful improvement in overall survival in patients from Asia; risk of ...
06/06/16 07:34 AM8:34 am Threshold Pharma highlights multiple presentations at ASCO; Presentation of additional subset data from Phase 3 MAESTRO trial of evofosfamide in pancreatic cancer demonstrates meaningful improvement in overall survival in patients f -
06/04/16 09:55 AMStocks Update: Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) , Acceleron Pharma Inc. (NASDAQ:XLRN) - Is stories
06/03/16 09:48 AMBroker Watchlist: Threshold Pharmaceuticals, Inc. (THLD) - Share Trading News
06/01/16 09:47 AMThreshold Pharmaceuticals Inc. (THLD) Jumps 7.17% on May 30 - Equities.com - Threshold Pharmaceuticals Inc. (THLD) Jumps 7.17% on May 30Equities.comThreshold Pharmaceuticals Inc. (THLD) was among the biggest gainers on the Russell 2000 for Monday May 30 as the stock popped 7.17% to $0.48, representing a gain of $0.0321 per share. Some 571,228 shares traded hands on 880 trades, compared with ...and more »
06/01/16 07:33 AMThreshold Pharmaceuticals to Present at Jefferies 2016 Healthcare Conference - [at noodls] - June 1, 2016 Company Presentation Scheduled for June 7, 2016 at 3:30 p.m. ET SOUTH SAN FRANCISCO, Calif., June 01, 2016 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) today announced ...
05/31/16 09:53 AMTraded Price Fluctuations to Observe: Cerus Corporation (NASDAQ:CERS) , Threshold Pharmaceuticals, Inc ... - Street Updates - Traded Price Fluctuations to Observe: Cerus Corporation (NASDAQ:CERS) , Threshold Pharmaceuticals, Inc ...Street UpdatesThreshold Pharmaceuticals, Inc. (NASDAQ:THLD) after beginning at $0.4600, closed at $0.4795 by building up +7.1748% in recent trading session. Most recent session's volume of 571.23 thousand shares lower than its average volume of 1.1 million shares.
05/30/16 10:23 PMNext Weeks Broker Price Targets For Threshold Pharmaceuticals, Inc. (THLD) - Share Trading News - Next Weeks Broker Price Targets For Threshold Pharmaceuticals, Inc. (THLD)Share Trading NewsThreshold Pharmaceuticals, Inc. has a 50 day moving average of 0.41 and a 200 day moving average of 0.88. The stock's market capitalization is 34.29M, it has a 52-week low of 0.21 and a 52-week high of 5.28. The share price of the company (THLD) was ...Threshold Pharmaceuticals Incorporated (NASDAQ:THLD) Sellers Increased By 0.97% Their ShortsFranklin Independentall 2 news articles »
05/28/16 05:26 PMThreshold Pharmaceuticals, Inc. (NASDAQ:THLD) Quarterly EPS From Continuing Operations Stands At $-0.1098 - Stocks Daily - Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) Quarterly EPS From Continuing Operations Stands At $-0.1098Stocks DailyFor the year ended 2016-03-31 Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) basic consolidated EPS reported was $0.6239. For the quarter ended 2016-03-31, it came at $0.6239. EPS is a part of a firm's earnings that is owed to each outstanding stock.
05/27/16 10:55 PMThreshold Pharmaceuticals Inc. (THLD) Jumps 7.17% on May 27 - Equities.com - Threshold Pharmaceuticals Inc. (THLD) Jumps 7.17% on May 27Equities.comThreshold Pharmaceuticals Inc. (THLD) was among the biggest gainers on the Russell 2000 for Friday May 27 as the stock popped 7.17% to $0.48, representing a gain of $0.0321 per share. Some 569,228 shares traded hands on 878 trades, compared with ...and more »
05/26/16 05:37 PMWhat's New with Threshold Pharmaceuticals, Inc. (NASDAQ:THLD)? - The Point Review - The Point ReviewWhat's New with Threshold Pharmaceuticals, Inc. (NASDAQ:THLD)?The Point ReviewShare of Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) traded on 2.20 percent above secure line at 3:44PM EDT in order to take the company's stock at the price of $0.460. At the time of writing the stock exchanged hands 1.07 million shares versus ...Summary of Stock's Moves: NuVasive, Inc. (NASDAQ:NUVA) , Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) ,Street UpdatesThreshold Pharmaceuticals Incorporated (NASDAQ:THLD) Shorted Shares Increased 4.51% After Market SellingFranklin Independentall 3 news articles »
05/26/16 08:50 AMInsiders Are Gradually Buying Threshold Pharmaceuticals Inc. (NASDAQ:THLD) - Wall Street Hints and News - Insiders Are Gradually Buying Threshold Pharmaceuticals Inc. (NASDAQ:THLD)Wall Street Hints and NewsAccording to the latest SEC filings, insiders at Threshold Pharmaceuticals Inc. (NASDAQ:THLD) have increased their position in the stock by 5.24% over the past 6 months. Insiders now own 0.10% of total outstanding shares. There are both legal and ...and more »
05/26/16 08:50 AMSummary of Stock's Moves: NuVasive, Inc. (NASDAQ:NUVA) , Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) , - Street Updates - Summary of Stock's Moves: NuVasive, Inc. (NASDAQ:NUVA) , Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) ,Street UpdatesOn 5/25/2016, shares of NuVasive, Inc. (NASDAQ:NUVA) fell -0.65% in trading session and finally closed at $53.80. The company most recent volume stood at 258.37 thousand shares as compared to its average volume of 772.15 thousand shares. Over the ...
05/25/16 05:29 PMThreshold Pharmaceuticals Inc. (THLD) Jumps 6.86% on May 25 - Equities.com - Threshold Pharmaceuticals Inc. (THLD) Jumps 6.86% on May 25Equities.comThreshold Pharmaceuticals Inc. (THLD) was among the biggest gainers on the Russell 2000 for Wednesday May 25 as the stock popped 6.86% to $0.45, representing a gain of $0.0289 per share. Some 698,910 shares traded hands on 982 trades, compared ...and more »
05/24/16 09:15 AMThreshold Pharmaceuticals, Inc. (NASDAQ:THLD) Impact Score At 66 - Investor Newswire - Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) Impact Score At 66Investor NewswireAlpha One explored various online articles released on Threshold Pharmaceuticals, Inc. (NASDAQ:THLD), and it set a daily sentiment score of 0.31 on the company. The entity has an algorithm in place to know stock sentiment on the share after exploring ...and more »
05/20/16 10:37 PMThreshold Pharmaceuticals, Inc. (THLD) Updated Broker Price Targets - Share Trading News - Threshold Pharmaceuticals, Inc. (THLD) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Threshold Pharmaceuticals, Inc. (THLD). The latest reports which are currently in issue on Friday 20th of May state 0 analysts have a rating of “strong buy”, 0 analysts ...
05/19/16 10:42 PMInsiders Are Buying Threshold Pharmaceuticals Inc. (NASDAQ:THLD) - Wall Street Hints and News - Insiders Are Buying Threshold Pharmaceuticals Inc. (NASDAQ:THLD)Wall Street Hints and NewsAccording to the latest SEC filings, insiders at Threshold Pharmaceuticals Inc. (NASDAQ:THLD) have increased their position in the stock by 5.16%. Insiders now own 0.10% of total outstanding shares. There are both legal and illegal types of insider ...and more »
05/19/16 05:34 PMRevenue Update on Threshold Pharmaceuticals(NASDAQ:THLD) - Trade Calls - Revenue Update on Threshold Pharmaceuticals(NASDAQ:THLD)Trade CallsThreshold Pharmaceuticals(NASDAQ:THLD) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during After-hours on May 5, 2016. Company reported revenue of $0.00. Analysts estimated a revenue of $12.00M. Earnings per ...
05/17/16 10:31 PMThreshold Pharmaceuticals Inc. (THLD) Jumps 9.67% on May 16 - Equities.com - Threshold Pharmaceuticals Inc. (THLD) Jumps 9.67% on May 16Equities.comThreshold Pharmaceuticals Inc. (THLD) was among the biggest gainers on the Russell 2000 for Monday May 16 as the stock popped 9.67% to $0.37, representing a gain of $0.0324 per share. Some 331,389 shares traded hands on 625 trades, compared with ...
05/17/16 05:23 PMHot Alert: Threshold Pharmaceuticals Inc. (NASDAQ:THLD), Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), Verizon ... - KC Register - Hot Alert: Threshold Pharmaceuticals Inc. (NASDAQ:THLD), Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), Verizon ...KC RegisterOn 5 May, Threshold Pharmaceuticals Inc. (NASDAQ:THLD) reported General and administrative expenses were $2.2 million for the first quarter of 2016 compared to $2.6 million for the same period in 2015. The decrease in general and administrative ...and more »
05/14/16 12:04 PMTHRESHOLD PHARMACEUTICALS INC Financials -
05/12/16 05:53 PMEarnings Review: Threshold Pharmaceuticals (THLD) - News Oracle - Earnings Review: Threshold Pharmaceuticals (THLD)News OracleLast Trade: The Company rose 3.83% and finished at $0.350. The daily volume was measured at 555,348.00 shares. The 52-week high of the share price is $5.28 and the 52-week low is $0.21. The company has a market cap of $26.40 million. The stock has ...and more »
05/11/16 05:56 PMPerformance Recap and Target Perspective on Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) - B.O.D.Y Confidential - Performance Recap and Target Perspective on Threshold Pharmaceuticals, Inc. (NASDAQ:THLD)B.O.D.Y ConfidentialIn the latest trading session, shares of Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) moved +3.83%. In order to gain some further insight on stock performance, we can take a look at the stock price relative to some moving averages. After a recent ...and more »
05/11/16 05:56 PMThreshold Pharmaceuticals Inc. (THLD) Jumps 5.48% on May 10 - Equities.com - Threshold Pharmaceuticals Inc. (THLD) Jumps 5.48% on May 10Equities.comThreshold Pharmaceuticals Inc. (THLD) was among the biggest gainers on the Russell 2000 for Tuesday May 10 as the stock popped 5.48% to $0.34, representing a gain of $0.0175 per share. Some 338,827 shares traded hands on 913 trades, compared ...and more »
05/10/16 10:56 PMStock's Earnings Analysis Report: Threshold Pharmaceuticals (NASDAQ:THLD) - News Oracle - News OracleStock's Earnings Analysis Report: Threshold Pharmaceuticals (NASDAQ:THLD)News OracleLast Trade: The Company fell -6.06% and finished at $0.320. The daily volume was measured at 1.27 million shares. The 52-week high of the share price is $5.28 and the 52-week low is $0.21. The company has a market cap of $19.25 million. The stock has a ...and more »
05/09/16 05:42 PMHC Stocks Zone: Threshold Pharmaceuticals Inc. (THLD), Ibio Inc (IBIO), Cempra Inc (CEMP) - share market updates (press release) - News OracleHC Stocks Zone: Threshold Pharmaceuticals Inc. (THLD), Ibio Inc (IBIO), Cempra Inc (CEMP)share market updates (press release)Shares of Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) ended Friday session in red amid volatile trading. The shares closed down -0.064 points or -15.79% at $0.340 with 2.25 million shares getting traded. Post opening the session at $0.40, the shares ...Earnings overview: Threshold Pharmaceuticals, Inc. (NASDAQ:THLD)News Oracleall 2 news articles »
05/08/16 05:58 PMAfter Last Week What Do Analysts Think Of Threshold Pharmaceuticals, Inc. (THLD) - Share Trading News - After Last Week What Do Analysts Think Of Threshold Pharmaceuticals, Inc. (THLD)Share Trading NewsThe share price of Threshold Pharmaceuticals, Inc. (THLD) was down -15.79% during the last trading session, with a day high of 0.42. 2251222 shares were traded on Threshold Pharmaceuticals, Inc.'s last session. The stock's 50 day moving average is 0.45 ...
05/05/16 06:06 PMAverage Analyst Rating for Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) - B.O.D.Y Confidential - Average Analyst Rating for Threshold Pharmaceuticals, Inc. (NASDAQ:THLD)B.O.D.Y ConfidentialWall Street analysts have provided an average broker recommendation of 2.5 on Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) shares. The rating is determined by using the average of all analyst recommendations taken into consideration by Zacks ...and more »
05/05/16 05:28 PMThreshold Pharmaceuticals posts 1Q loss -
05/05/16 03:21 PMThreshold Pharmaceuticals Reports First Quarter Financial Results - [at noodls] - May 5, 2016 SOUTH SAN FRANCISCO, Calif., May 05, 2016 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD), a clinical-stage biopharmaceutical company developing novel therapies for cancer, ...
04/29/16 02:32 PMETF’s with exposure to Threshold Pharmaceuticals, Inc. : April 29, 2016 -
04/28/16 04:23 AMThreshold Pharmaceuticals, Inc. (NASDAQ:THLD) Share Rating Recap - B.O.D.Y Confidential - Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) Share Rating RecapB.O.D.Y ConfidentialShares of Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes mainly ...and more »
04/27/16 11:10 PMThreshold Pharmaceuticals Inc. (THLD) is Trading Higher on Unusual Volume for April 26 - Equities.com - Threshold Pharmaceuticals Inc. (THLD) is Trading Higher on Unusual Volume for April 26Equities.comThreshold Pharmaceuticals Inc. (THLD) experienced unusually high volume on Apr. 26, as the stock gained 1.71% to a closing price of $0.47. The stock saw 1.6 million shares trade hands over the course of the day on 1,998 trades. Given that the stock's ...Threshold Pharmaceuticals, Inc. (THLD) Analyst ReviewRisers & Fallersall 2 news articles »
04/27/16 06:01 PMTrading updates about two Stocks: Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) , Inovio Pharmaceuticals, Inc ... - Street Updates - Trading updates about two Stocks: Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) , Inovio Pharmaceuticals, Inc ...Street UpdatesOn 4/26/2016, Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) ended trading session higher at $0.4699 with +1.7100%. The company traded a volume of 1.6 million shares as comparison to average volume of 1.02 million shares. During the 52 –week ...and more »
04/27/16 06:01 PMThreshold Pharmaceuticals, Inc. (THLD) Analyst Review - Risers & Fallers - Threshold Pharmaceuticals, Inc. (THLD) Analyst ReviewRisers & FallersA number of investment brokers have recently updated their price targets on shares of Threshold Pharmaceuticals, Inc. (THLD). According to the latest broker reports outstanding on Wednesday 27th of April, 0 analysts have a rating of “strong buy”, 0 ...
03/28/16 08:40 AMETF’s with exposure to Threshold Pharmaceuticals, Inc. : March 28, 2016 -
03/21/16 07:18 AMThreshold Pharmaceuticals Appoints Stew Kroll as Chief Operating Officer - [at noodls] - March 21, 2016 SOUTH SAN FRANCISCO, Calif., March 21, 2016 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD), a clinical-stage biopharmaceutical company developing novel therapies for cancer, ...
03/18/16 10:30 AMThreshold (THLD): Evofosfamide May Be Effective in Some Pancreatic Cancer Patients -
03/17/16 09:00 AMETF’s with exposure to Threshold Pharmaceuticals, Inc. : March 17, 2016 -
About Threshold Pharmaceuticals

Threshold Pharmaceuticals logoThreshold Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of therapeutic and diagnostic agents that selectively target tumor cells for the treatment of patients living with cancer. It is developing two therapeutic product candidates based on hypoxia-activated prodrug technology: evofosfamide and tarloxotinib. Evofosfamide is designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not in healthy tissues. Tarloxotinib is under investigation in two Phase II proof-of-concept trials: one for the treatment of patients with mutant EGFR-positive, T790M-negative advanced NSCLC progressing on an EGFR TKI, and the other for patients with recurrent or metastatic squamous cell carcinomas of the head and neck. [18F]-HX4 is an investigational Positron Emission Tomography imaging agent for hypoxia to identify and quantify the degree of hypoxia in tumors in vivo.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: THLD
  • CUSIP: 88580720
Key Metrics:
  • Previous Close: $0.38
  • 50 Day Moving Average: $0.42
  • 200 Day Moving Average: $0.41
  • P/E Ratio: 0.65
  • P/E Growth: 0.00
  • Market Cap: $27.17M
  • Current Quarter EPS Consensus Estimate: $-0.33 EPS
Additional Links:
Threshold Pharmaceuticals (NASDAQ:THLD) Chart for Monday, June, 27, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha